Tech engineering recruitment platform Codility has appointed Tangent to deliver a brand refresh and a complete redesign of its digital platform.
Read more here.
The post [Codility in The Drum] Tangent launch new website for B2B tech scale-up Codility appeared first on OurCrowd.
Block-chain and crypto-currency have seen massive product growth over the past year. Enterprises ranging from supply-chain management to multi-jurisdiction financing have found new and powerful uses for these futuristic concepts.
The LoveChain approaches the immutable nature of cryptographically-secure content a little differently. It reimagines the blockchain as a hypermedia scrapbook, a lovingly-assembled and permanent record of the most important loves in our lives.
To that end, their blockchain allows users to enjoy the ease-of-use associated with traditional social media platforms, but without any fear of losing one’s account and one’s precious memories.
Permanent immutability is just one of the benefits that users accrue while posting about the people, places and things that they love. Much like the Bitcoin blockchain, The LoveChain includes a complete, tokenized economic ecosystem.
For every memory that users record on The LoveChain, they receive payment, from the chain, in the form of reward tokens. These tokens, once collected, can be used to make purchases with, or acquire discounts from, the multiple different large-chain and boutique vendors who have partnered with the service.
Participation in the social milieu of love chain, just as one would naturally participate in the various discussions on Twitter and Facebook, allows users to accrue more tokens, thereby building out new partnership opportunities, with guaranteed customers, for the love chain’s promoters.
The LoveChain was founded by developer Omar Diab in 2019, and can be found online at http://www.thelovechain.io. It’s an interesting concept, one that ties the ancient “forever” nature of true love with the modern “forever” publishing model of the blockchain.
By ensuring that lovers’ posts remain online, and in their control, The LoveChain offers a valuable alternative to unregulated social publishing platforms that can delete one’s profiles and memories at a whim.
Francesca Chia had an idea she was developing on the side of her consultancy job in Malaysia, though she didn’t think it was anything serious starting out. Over the course of nine months, that all changed.
Forbes – Startups
Sheltering in place during the Covid-19 pandemic, my coffees with current and ex-students (entrepreneurs, as well as employees early in their careers) have gone virtual. Pre-pandemic these coffees were usually about what startup to join or how to find product/market fit. Though in the last month, even through Zoom I could sense they were struggling with a much weightier problem. The common theme in these calls were that many of them were finding this crisis to be an existential wakeup call. “My job feels pretty meaningless in the big picture of what matters. I’m thinking about what happens when I can go back to work. I’m no longer sure my current career path is what I want to do. How do I figure it out?”
Here’s what I’ve told them.
In a Crisis – An Opportunity to Reflect
If you’re still in school, or early in your career, you thought you would graduate into a strong economy and the road ahead had plenty of opportunities. That world is gone and perhaps not returning for a year or more. Economies across the world are in a freefall. As unemployment in the U.S. passes 15%, the lights are going off in companies, and we won’t see them back on for a long time. Some industries will never be the same. Internships and summer work may be gone, too.
But every crisis brings an opportunity. In this case, to reassess one’s life and ask: How do I want to use my time when the world recovers?
What I suggested was, that the economic disruption caused by the virus and the recession that will follow is one of those rare opportunities to consider a change, one that could make your own life more meaningful, allow you to make an impact, and gain more than just a salary from your work. Perhaps instead of working for the latest social media or ecommerce company or in retail or travel or hospitality, you might want to make people live healthier, longer and more productive lives.
I pointed out that if you’re coming out of school or early in your career you have an edge – You have the most flexibility to reevaluate you trajectory. You could consider alternate vocations – medical research or joining a startup in therapeutics, diagnostics, medical devices, or digital health (mobile health, health IT, wearable devices, telemedicine, and personalized medicine). Or become an EMT, doctor or nurse. Or consider the impact remote learning has had in the pandemic. How can you make it better and more effective? What are ways you might help to strengthen organizations that help those less able and less fortunate?
Here are the steps you can take to get started:
Use the customer discovery methodology to search for new careers.
- Start by doing some reading and research, looking to the leading publications in the field you’re interested in learning more about. News sources for Digital Health and Life Sciences are different from software/hardware blogs such as Hacker News, TechCrunch, etc.
If you’re interested in learning more about a career in Life Sciences, start reading:
- Medgadget– medical technology blog
- MobiHealth News
- Science Daily – medical research news
- NEJM Frontiers in Medicine – New England Journal of Medicine
- FierceHealthIT, FierceBiotech, FierceMedtech
- Medcity News – news about the business of healthcare innovation
- MDDI+QMED – Medical Device and Diagnostic Industry
- In the Pipeline – commentary on drug discovery and the pharma industry
- Xconomy – news and trends in life science
- CBInsights – Startups in health
- Reddit – search for topics of interest
If you’re thinking about educational technology start by reading EdSurge
And if you’re thinking about getting involved in social entrepreneurship, read The Stanford Social Innovation Review as well as the social entrepreneurship sections of publications like Entrepreneur, Inc., Fast Company and Forbes.
- Get out of the building (virtually) and talk to people in the professions you’re interested in. (People on the front-line of the Covid-19 fight (e.g. first responders, health care workers) might be otherwise engaged, but others in the field may be available to chat.) Learn about the job, whether they enjoy it and how you can get on that career track.
- Get out of the building physically. If possible, volunteer for some front-line activities. Think about internships in the new fields you’re exploring.
- If you’re thinking of starting a company, get to know the VC’s. They are different depending on the type of startup you’re building. Unlike in the 20th century where most VC’s financed hardware, software and life sciences, today therapeutics, diagnostics, and medical devices, are funded via VC firms that specialize in only those domains. Digital health crosses the boundaries and may be founded by all types of firms. Get to know who they are.
Some of the Life Science VC blogs and podcasts:
- Rock Health News – digital health VC news
- LifeSciVC – Bruce Booth Atlas Ventures
- A Healthy Dose – Bessemer Partners Podcast
- The Long Run – Biotech Podcast
For edtech the VC firm to know is Reach Capital
- Inexpensively pivot your education into a new field. An online education could be a viable alternative to expensive college debt. Coursera, EdX and ClassCentral have hundreds of on-line classes in medicine, health and related fields. Accredited universities also offer online programs (see here.) If you’re in school, take some classes outside your existing major (example here.)
My advice in all of these conversations? Carpe Diem – seize the day.
Now is the time to ask: Is my work relevant? Am I living the life I really wanted? Does the pandemic change the weighting of what’s important?
Make your life extraordinary.
- Your career will only last for 14,000 days
- If you’re still in school, reconsider your major or where you thought it was going to take you
- If you’re early in your career, now is the time to consider what it would take to make a pivot
- In the end, the measure of your life will not be money or time. It’s the impact you make serving God, your family, community, and country. In the end, our report-card will be whether we left the world a better place.
Welcome to this week’s Fundraising Thursdays Thread.
Ask about anything related to fundraising, investors, accelerators, grants, and other sources of capital.
That includes how to find these sources, how to work with them, and how to negotiate with them.
Don’t be shy. The purpose of this is to learn and share ideas and methodologies with one another.
Any question is a good question!
If you are answering questions, remember to be kind and supportive. Many are just starting out and have no idea what they are doing. That’s okay! We all knew nothing before we knew something.
You can also find more support using instant chat on the /r/startups discord.
SF-based CRISPR diagnostics startup Mammoth Biosciences has published the first peer-reviewed study that shows validation of using its testing method to detect the presence of COVID-19 in patients. The study, published in Nature, shows performance on par with existing PCR-based molecular tests, the one ones currently authorized for use by the FDA to test for the novel coronavirus.
Mammoth’s DETECTR platform is designed to have advantages over traditional testing methods in a few different ways, including in its reconfigurability to address new viruses, since it uses CRISPR to target specific genetic sequences, and activate a “cleavage” that effectively acts as a signal for the diagnostic equipment to pick up. Basically, in the same way CRISPR allows scientists to target a specific string of DNA for removal or alteration, with scalpel-like precision, Mammoth’s diagnostic allows for programmable, targeted matching with a reference string, leading to confirmation that viral RNA is present in the patient.
The test that Mammoth is developing showed validated use in under two weeks, the researchers claim, since their platform is designed from the ground up for rapid reconfigurability to address new viral threats. The test can deliver results in under 45 minutes, and the results delivery is via what’s called a ‘lateral flow strip,’ which is essentially the same kind of read-out you see with at-home pregnancy tests, making them relatively easy to interpret. DETECTR also doesn’t require a lab setting to delver results, and instead can be conducted with portable heat blocks, combined with commonly available standard reagents.
In the study, which included samples from 36 patients with confirmed COVID-19 infections, and 42 patients who had other types of viral respiratory infections, the tests showed 95% positive diagnostic accuracy, and 100% negative efficacy. Samples used were taken from respiratory swabs.
This doesn’t mean this test can roll out to actual sites for use, but it’s a good validation of Mammoth’s model and test design, and could eventually lead to actual deployment of its test in a clinical setting, providing other, larger-scale studies back up the data.